The discovery of the Estrogen Receptor Beta (ERβ) in 1996 opened new perspectives in the
diagnostics and therapy of different types of cancer. Here, we present a review of the …

… estrogen receptor-related putative breast cancer biomarkers, including those of putative breast
cancer stem cells, a minor population of estrogen receptor … a few promising cytoskeleton …

… Many EDCs interact with and modulate the activity of the two estrogen receptors (ERα and
ERβ) which regulate the effects of estrogen hormones including estradiol (E2) on the growth, …

… The role of estrogen receptor beta (ER-β) in breast cancer (BC) remains unclear. Some
studies have suggested that ER-β may oppose the actions of estrogen receptor alpha (ER-α), …

… More than 10 years have passed since the discovery of the second estrogen receptor, estrogen
receptor β (… Therefore, targeting angiogenesis is a promising new therapy in oncology. …

… Citation1 These pleiotropic effects of estrogen are related to estrogen receptors (ERs) which
… Therefore, ER-α36 is a promising biomarker for tumor behavior and therapeutic response, …

… estrogen exposure is a well-known major risk factor for endometrial cancer. Recent data has
suggested that estrogen receptor … (EMT), could be a promising prognostic marker [7], [8], [9]. …

… clinicopathological indicators and mRNA profiles of estrogen receptors (ERs) and ErbB …
3,B), indicating that the prognostic potential of ERRβ is not promising. However, ERβ mRNA …

… The potency of the agents is low, but promising results have been … Estrogen receptor beta
is reported to be expressed more … Estrogen receptor alpha might be a biomarker that predicts …

Estrogen receptor (ER) plays important roles in gene … Selective estrogen receptor modulators
(SERMs) and aromatase … Fulvestrant, the only approved selective estrogen receptor …